Ampyra (Dalfampridine)

Dalfampridine is a medicine that helps adults with multiple sclerosis (MS) walk better. It is taken as a pill. It works by helping damaged nerves send signals more strongly.

Brand names:Dalfampridine, Fampridine, Ampyra
Medication

What people taking Ampyra (Dalfampridine) report

Every report comes from a Lived member, sent anonymously.

Have you tried Ampyra (Dalfampridine) for MS (Multiple Sclerosis)?

NameHow it went

About Ampyra (Dalfampridine)

What It's For

Dalfampridine, sold under the brand name Ampyra and also available as a generic, is a prescription tablet that helps some adults with multiple sclerosis (MS) walk faster. It is approved for adults with any of the main forms of MS, whether the disease comes in relapses or progresses steadily. Dalfampridine treats a symptom rather than the disease itself. It does not slow MS, prevent relapses or repair nerve damage, so it is used alongside, not instead of, the disease-modifying therapies that aim to control MS activity. Physical therapy, exercise and walking aids remain part of improving mobility whether or not the medicine helps. The drug's chemical name is 4-aminopyridine, and outside the US the same ingredient is called fampridine (sold in Europe as Fampyra).

How It Works

Nerve fibers carry signals as tiny electrical pulses, and in healthy nerves a fatty coating called myelin keeps those pulses moving quickly. MS strips away patches of myelin. Where the coating is damaged, potassium leaks out through channels in the exposed nerve fiber, which weakens the signal and can stop it before it reaches the muscles. Dalfampridine blocks those potassium channels. In laboratory studies this helps signals travel through damaged sections of nerve, so commands from the brain reach the leg muscles more reliably. That is thought to explain the faster walking some people notice, although researchers have not fully worked out how the drug produces its benefit.

Dosage & Administration

Dalfampridine comes as a 10 mg extended-release tablet, taken twice a day about 12 hours apart, with or without food. This is also the maximum dose. Higher doses were not more effective in studies and made seizures more likely. The tablet releases the drug slowly, so swallow it whole. Splitting, crushing, chewing or dissolving it can release too much at once. If you miss a dose, skip it and take the next one at the usual time; never take a double or extra dose, and never take more than two tablets in 24 hours. Because the kidneys clear the drug, a blood test to estimate kidney function (creatinine clearance) is done before starting and at least once a year afterward. Even mildly reduced kidney function, which is common after age 50, can raise drug levels toward the range linked to seizures.

Side Effects

In clinical trials, the side effects that showed up more often than with placebo included urinary tract infections, trouble sleeping, dizziness, headache, nausea, weakness, back pain and balance problems. About 4 percent of people stopped treatment because of side effects, compared with 2 percent on placebo. Dizziness or vertigo can affect driving, so see how you react before getting behind the wheel. The most important risk is a seizure. Most seizures reported with dalfampridine happened at the standard dose, in people who had never had one before, and within days to weeks of starting. Anyone who has a seizure while taking it should stop the medicine, contact the prescriber right away, and not take it again. Severe allergic reactions are rare. If you develop trouble breathing, hives, or swelling of the throat or tongue, stop taking dalfampridine and get emergency medical care.

Interactions & Warnings

Dalfampridine is not used in people who have ever had a seizure, in people with moderate or severe kidney impairment, or in anyone who has had an allergic reaction to it or to 4-aminopyridine. Do not take it together with any other form of 4-aminopyridine, such as compounded fampridine from a specialty pharmacy, because the active ingredient is the same and the doses would add up. Cimetidine, an acid reducer sold over the counter for heartburn as well as by prescription, can slow the kidneys' removal of dalfampridine and raise seizure risk; tell the prescriber and pharmacist before starting it or any other new medicine. The muscle relaxant baclofen, often used for MS stiffness, does not appear to interact. There is little information about dalfampridine during pregnancy, and animal studies raised concerns about offspring survival and growth. Anyone pregnant, planning a pregnancy or breastfeeding should weigh the walking benefit against unknown risks with their neurologist.

What to Expect

Dalfampridine helps some people but not most. In the two main trials, roughly a third to two-fifths of people taking it walked consistently faster, compared with fewer than one in ten on placebo. Benefit appeared across all types of MS. People whose walking sped up also tended to rate their walking as easier, though the drug did not clearly beat placebo on that self-rating. If it is going to help, the change usually shows within the first few weeks. European prescribing guidance builds in a two- to four-week trial, using a timed walk test or a walking questionnaire, and stopping if walking has not improved. People who do benefit generally keep taking it, with yearly kidney checks. If walking later declines, the same guidance suggests a pause to see whether the medicine is still making a difference.

Questions to Ask Your Doctor

  1. 1.How will we measure whether dalfampridine is improving my walking, and how long should we try it before deciding?
  2. 2.Is my kidney function good enough for this medicine, and how often will you check it?
  3. 3.Do any of my current medicines or supplements, including heartburn remedies, raise my seizure risk with dalfampridine?
  4. 4.How does this fit with my physical therapy, exercise plan and disease-modifying treatment?
  5. 5.If it stops helping or I want to try pregnancy, how would we stop it?

Last reviewed • Oct 2026

Educational content, not medical advice.